BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28822076)

  • 1. Studies of the benzopyran class of selective COX-2 inhibitors using 3D-QSAR and molecular docking.
    Yadav DK; Saloni ; Sharma P; Misra S; Singh H; Mancera RL; Kim K; Jang C; Kim MH; Pérez-Sánchez H; Choi EH; Kumar S
    Arch Pharm Res; 2018 Dec; 41(12):1178-1189. PubMed ID: 28822076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computer-aided identification of natural lead compounds as cyclooxygenase-2 inhibitors using virtual screening and molecular dynamic simulation.
    Ounissi M; Kameli A; Tigrine C; Rachedi FZ
    Comput Biol Chem; 2018 Dec; 77():1-16. PubMed ID: 30195234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, docking simulation, biological evaluations and 3D-QSAR study of 5-Aryl-6-(4-methylsulfonyl)-3-(metylthio)-1,2,4-triazine as selective cyclooxygenase-2 inhibitors.
    Irannejad H; Kebriaieezadeh A; Zarghi A; Montazer-Sadegh F; Shafiee A; Assadieskandar A; Amini M
    Bioorg Med Chem; 2014 Jan; 22(2):865-73. PubMed ID: 24361187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D-QSAR CoMFA/CoMSIA studies on 5-aryl-2,2-dialkyl-4-phenyl-3(2H)-furanone derivatives, as selective COX-2 inhibitors.
    Puntambekar DS; Giridhar R; Yadav MR
    Acta Pharm; 2006 Jun; 56(2):157-74. PubMed ID: 16613723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of pyridazinone derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents.
    Ahmed EM; Kassab AE; El-Malah AA; Hassan MSA
    Eur J Med Chem; 2019 Jun; 171():25-37. PubMed ID: 30904755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D-QSAR and Molecular Docking Studies on Oxadiazole Substituted Benzimidazole Derivatives: Validation of Experimental Inhibitory Potencies Towards COX-2.
    Asati V; Ghode P; Bajaj S; Jain SK; Bharti SK
    Curr Comput Aided Drug Des; 2019; 15(4):277-293. PubMed ID: 30280671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, biological evaluation and docking analysis of 3-methyl-1-phenylchromeno[4,3-c]pyrazol-4(1H)-ones as potential cyclooxygenase-2 (COX-2) inhibitors.
    Grover J; Kumar V; Sobhia ME; Jachak SM
    Bioorg Med Chem Lett; 2014 Oct; 24(19):4638-4642. PubMed ID: 25219899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential structural profile of a dual functional inhibitor against cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and 3D-QSAR analyses on DHDMBF analogues.
    Zheng M; Zhang Z; Zhu W; Liu H; Luo X; Chen K; Jiang H
    Bioorg Med Chem; 2006 May; 14(10):3428-37. PubMed ID: 16458008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacophore generation and atom-based 3D-QSAR of novel 2-(4-methylsulfonylphenyl)pyrimidines as COX-2 inhibitors.
    Shah UA; Deokar HS; Kadam SS; Kulkarni VM
    Mol Divers; 2010 Aug; 14(3):559-68. PubMed ID: 19669924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based parallel medicinal chemistry approach to improve metabolic stability of benzopyran COX-2 inhibitors.
    Xing L; Hamper BC; Fletcher TR; Wendling JM; Carter J; Gierse JK; Liao S
    Bioorg Med Chem Lett; 2011 Feb; 21(3):993-6. PubMed ID: 21215625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of phenylpiperazine derivatives of 1,4-benzodioxan as selective COX-2 inhibitors and anti-inflammatory agents.
    Sun J; Wang S; Sheng GH; Lian ZM; Liu HY; Zhu HL
    Bioorg Med Chem; 2016 Nov; 24(21):5626-5632. PubMed ID: 27658794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative structure-activity relationship analysis of a series of 2,3-diaryl benzopyran analogues as novel selective cyclooxygenase-2 inhibitors.
    Prasanna S; Manivannan E; Chaturvedi SC
    Bioorg Med Chem Lett; 2004 Aug; 14(15):4005-11. PubMed ID: 15225716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, anti-inflammatory activity, and molecular docking studies of perimidine derivatives containing triazole.
    Zhang HJ; Wang XZ; Cao Q; Gong GH; Quan ZS
    Bioorg Med Chem Lett; 2017 Sep; 27(18):4409-4414. PubMed ID: 28823493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, antitumour activities and molecular docking of thiocarboxylic acid ester-based NSAID scaffolds: COX-2 inhibition and mechanistic studies.
    El-Azab AS; Abdel-Aziz AA; Abou-Zeid LA; El-Husseiny WM; El Morsy AM; El-Gendy MA; El-Sayed MA
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):989-998. PubMed ID: 29806488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspective assessment of COX-1 and COX-2 selectivity of nonsteroidal anti-inflammatory drugs from clinical practice: use of genetic function approximation.
    Zambre AP; Ganure AL; Shinde DB; Kulkarni VM
    J Chem Inf Model; 2007; 47(2):635-43. PubMed ID: 17256838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a potent cyclooxygenase-2 inhibitor, S4, through docking-based pharmacophore screening, in vivo and in vitro estimations.
    Tseng TS; Chuang SM; Hsiao NW; Chen YW; Lee YC; Lin CC; Huang C; Tsai KC
    Mol Biosyst; 2016 Jul; 12(8):2541-51. PubMed ID: 27265567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel benzenesulfonamide and 1,2-benzisothiazol-3(2H)-one-1,1-dioxide derivatives as potential selective COX-2 inhibitors.
    Taher ES; Ibrahim TS; Fares M; Al-Mahmoudy AMM; Radwan AF; Orabi KY; El-Sabbagh OI
    Eur J Med Chem; 2019 Jun; 171():372-382. PubMed ID: 30928709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and molecular docking of new imidazoquinazolinones as analgesic agents and selective COX-2 inhibitors.
    Hassanein HH; Georgey HH; Fouad MA; El Kerdawy AM; Said MF
    Future Med Chem; 2017 Apr; 9(6):553-578. PubMed ID: 28394629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational studies of COX-2 inhibitors: 3D-QSAR and docking.
    Kim HJ; Chae CH; Yi KY; Park KL; Yoo SE
    Bioorg Med Chem; 2004 Apr; 12(7):1629-41. PubMed ID: 15028256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and biological evaluation of novel 1,2-diaryl-4-substituted-benzylidene-5(4H)-imidazolone derivatives as cytotoxic agents and COX-2/LOX inhibitors.
    Lamie PF; Philoppes JN; Rárová L
    Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700311. PubMed ID: 29400411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.